MedTrace Logo

Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development

NCT07343401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-01-15

No results posted yet for this study

Summary

Impact of Immunosuppressive Therapy for Sarcoidosis on Lymphoma Development

Conditions

  • Sarcoidosis Lung

Interventions

PROCEDURE

lymph node biopsy

sarcoidosis diagnosis by lymph node biopsy excisiona or bronchoscopic

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • ahmed mahmoud fawzy, professor · Alexandria University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-12-30
Completion
2026-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07343401 on ClinicalTrials.gov